Allergan Hits Watson With Patent Suit Over Combigan
Allergan Inc. has launched another patent infringement suit over its Combigan eye medication, targeting Watson Pharmaceutical Inc.'s efforts to market a generic version of the glaucoma drug....To view the full article, register now.
Already a subscriber? Click here to view full article